
The Peter Doherty Institute for Infection and Immunity at @UniMelbMDHS @theRMH. Research includes #HIV, #hepatitis, #malaria, #influenza #COVID19 & more.
Parkville, Melbourne, Victoria
Joined October 2014
- Tweets10.6K
- Following912
- Followers22.8K
- Likes5.3K
Congratulations to Dr Shivani Pasricha and Dr Sarah Baines on receiving Miller Foundation Global Health Fellowships!
Their research will advance STI diagnostics and antimicrobial resistance surveillance across the Asia-Pacific.
Read more: bit.ly/4z0tCBA
The McCusker Charitable Foundation has committed a further $3 million to advance immunology research at the Doherty Institute, supporting the development of more personalised treatments for autoimmune diseases, cancer and critical illness.
Read more: bit.ly/4dOwcST
Two Doherty Institute researchers have secured $2.17M in ARC Future Fellowships to explore fundamental questions in immunity – from how microbial exposure shapes the immune system to how T cells recognise small biological molecules.
Read more: bit.ly/4yKUUf3
Doherty Institute researchers have developed nanobodies that precisely recognise bacterial signals, opening new ways to control immune responses and target infected or cancerous cells with greater precision.
Read more: bit.ly/4i3sLtU
🔬 Doherty Institute researchers have combined CRISPR-Cas9 with long-read sequencing to detect rare RNA molecules during infection. The approach could help us better understand viruses and make RNA-based disease diagnosis more affordable.
Read more: bit.ly/4ynF4qL
Could Australia see a second flu peak this year? 📈 Experts share the latest influenza data, while continuing to monitor H5NI avian influenza in animals to support preparedness.
doherty.edu.au/articles/late…
Two new @nhmrc Centres for Research Excellence will support new research into hepatitis B virus, human T-lymphotropic virus type 1 and early-onset bowel cancer, with leadership and expertise from Doherty Institute researchers.
doherty.edu.au/articles/3-mi…
New evidence shows Buruli ulcer risk can be reduced by 80% through mosquito control in urban environments. A Melb study found specialised traps reduced mosquito numbers and led to fewer infections, offering a public health strategy ahead of spring/summer.
doherty.edu.au/articles/targ…
A major injury and severe COVID-19 might have more in common than we thought. New research has identified shared immune responses across both conditions, a finding that could help improve treatment for critically ill patients worldwide.
doherty.edu.au/articles/covi…
We're thrilled to see @KatherineKedz receive the 2026 GSK Award for Research Excellence 👏 Her team's discovery of the OLAH gene's role in severe respiratory disease could help improve how high-risk patients are identified and treated.
After an outstanding field of nominations from across Australia, Professor Katherine Kedzierska has been named the recipient of the 2026 GSK Award for Research Excellence.
The award recognises Australian researchers whose work has the potential to shape the future of healthcare through scientific discovery.
Professor Kedzierska, from the @TheDohertyInst and the University of Melbourne, has spent more than two decades working to answer one of the biggest questions in respiratory medicine:
Why do some people become critically ill from respiratory viral infections while others experience only mild disease?
Hear from Professor Kedzierska about how her research is helping unlock the immune mechanisms behind severe respiratory viral disease and why this year's recognition is so meaningful.
Congratulations Professor Kedzierska, on this well-deserved recognition.
#GSKARE #GSKAwardforResearchExcellence #GSKAustralia
Can Group C/G Streptococcus (Streptococcus dysgalactiae subsp. equisimilis, SDSE) become penicillin resistant? We report a case in an individual on prolonged penicillin prophylaxis. @MDaviesLab @TheDohertyInst journals.asm.org/doi/10.1128… 🧵👇
Doherty Institute retweeted
🦆 EXPERT REACTION: First case of H5 bird flu in a local Australian seabird detected
✨commentary from @TheDohertyInst @UNSW @Sydney_Uni @UTAS_ @Griffith_Uni @BirdlifeOz @CurtinUni @usceduau @latrobe @jane_younger @Acanthoplus @profesterman @DuckSwabber
scimex.org/newsfeed/expert-r…
Researchers have uncovered an ancient genetic change that may help explain how Mycobacterium tuberculosis evolved to evade the immune system, persist in the body and reactivate years later.
doherty.edu.au/articles/scie…
Are COVID-19 antivirals still an effective treatment option in 2026?
Clinical researchers share their perspective after reviewing large clinical trials in contemporary populations with more immunity.
doherty.edu.au/articles/stil…
New research reveals B cells do much more than produce antibodies - they also help activate and sustain T cells to fight chronic infections, like cancer or auto immune diseases.
bit.ly/4wdXKrw
A new study shows vaccination boosts immune responses, increasing B cells and antibodies, regardless of chronic health conditions. Findings help close a key gap in understanding vaccine responses in First Nations people.
doherty.edu.au/articles/aust…
Next-generation flu vaccine delivers a stronger immune response to the A(H3N2) influenza strain in a new clinical trial, outperforming traditional egg- and cell-grown vaccines and highlighting the potential for improved seasonal protection.
bit.ly/4uTCExz
Doherty Institute retweeted
🐥H5N1 bird flu has been detected in WA
Follow the link to read Australian commentary from @ANUmedia @TheKids_AU @UNSW @TheDohertyInst @MurdochUni @UTAS_ @MonashUni @UQ_News and @latrobe
scimex.org/newsfeed/expert-r…
#science #facts #knowledge #sciencefacts #birdflu #H5N1
On Saturday the first case of high pathogenicity avian influenza (HPAI) H5N1 was confirmed in Australia. What does this mean for our wildlife population? Origin, transmission and prevention measures explained by experts.
doherty.edu.au/articles/the-…
@DuckSwabber
Most people labelled “penicillin allergic” aren’t allergic. This World Allergy Week, Melb led trial highlights new model to safely rule it out through bedside testing in hospitals. ✅ Faster decisions
✅ Right antibiotics
✅ Better patient outcomes
bit.ly/4fV6eiu




